Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in ...
In February 2024, Corewell Health introduced pulsed field ablation, a treatment procedure significantly safer than previous AFib treatments, at several of its Michigan hospitals. PFA applies a ...
4d
News Medical on MSNChronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment targetA recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Regular flossing (at least once a week) may reduce the risk of stroke linked to blood clots from the heart and conditions ...
Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 ...
Regular tooth flossing is tied to a lower risk for ischemic stroke, primarily by reducing systemic inflammation, which can ...
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing ... atrial fibrillation, a condition that significantly raises the risks of ...
Afib patients with chronic inflammation have ... “Flossing is great for your teeth, but linking it directly to stroke prevention is tricky,” says Harlan Krumholz, MD, a professor of medicine ...
This article suggests the need to reconsider the benefits of using aspirin in stroke prevention ... in the production of this manuscript. Atrial fibrillation (AF) is the most common cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results